13 results match your criteria: "Infectious Diseases Clinical Pharmacist[Affiliation]"
Infez Med
September 2021
Research and Innovation Center, King Saud Medical City.
This is a systematic review of the literature specifically aimed to explore myocardial injury in coronavirus disease-19 (COVID-19) patients who were hospitalized with severe complicated infections. The medical literature was examined through the large medical databases, including Medline, Ovid, PubMed, and Embase, over the last year between January 2020 and May 2021. The search terms used were a combination of "myocardial injury" AND "COVID-19" AND "Hospitalization".
View Article and Find Full Text PDFInt J Antimicrob Agents
March 2022
Infectious Diseases Clinical Pharmacist, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153, USA.
The Infectious Diseases Society of America (IDSA) recommends numerous antibiotics for the treatment of urinary tract infections (UTIs) caused by extended-spectrum β-lactamase (ESBL)-producing bacteria. The purpose of this study was to evaluate clinical outcomes of oral step-down antibiotics compared with continued intravenous therapy in UTIs without bacteraemia. This multicentre, retrospective, cohort study was conducted in hospitalised patients with ESBL-producing UTIs between July 2016 and March 2020.
View Article and Find Full Text PDFFed Pract
June 2021
is a Hepatology Clinical Pharmacy Specialist, is an Infectious Diseases Clinical Pharmacist, is the Chief of the Gastroenterology and Hepatology Section, and is a Behavioral Health Psychologist, all at US Department of Veterans Affairs Northeast Ohio Healthcare System in Cleveland. Yngve Falck-Ytter is a Professor of Medicine, Erin Lea is an Adjunct Assistant Professor in the Department of Psychological Sciences, and Amy Hirsch is a Senior Clinical Instructor in the College of Medicine, all at Case Western Reserve University. Yngve Falck-Ytter is Faculty for the Gastroenterology Fellowship Program at University Hospitals.
Three patients reinfected with hepatitis C virus after a sustained virologic response were considered treatment naïve and treated with a short-course direct acting antiviral regimen.
View Article and Find Full Text PDFTher Adv Infect Dis
August 2021
Department of Medicine, Section of Infectious Diseases, University of Oklahoma Health Science Center, 800 Stanton L. Young Blvd., Suite 7300, Oklahoma City, OK 73104, USA.
Malaria, a parasitic disease caused by protozoa belonging to the genus , continues to represent a formidable public health challenge. Despite being a preventable disease, cases reported among travelers have continued to increase in recent decades. Protection of travelers against malaria, a potentially life-threatening disease, is of paramount importance, and it is therefore necessary for healthcare professionals to be up to date with the most recent recommendations.
View Article and Find Full Text PDFOrthop Nurs
October 2021
Rachel C. Larry, PharmD, PGY2 Infectious Diseases Pharmacy Resident, Midwestern University Chicago College of Pharmacy, Northwestern Memorial Hospital, Chicago, IL.
Antibiotic administration in the perioperative period is the foundation of preventing surgical site infections. β-Lactam antibiotics, notably the first-generation cephalosporin cefazolin, are the drugs of choice for this indication. However, reported antibiotic allergies often result in the use of suboptimal alternative agents that can lead to an increased risk of infection and adverse effects.
View Article and Find Full Text PDFAm J Health Syst Pharm
January 2016
Eun Kyoung Chung, Pharm.D., Ph.D., is Assistant Professor, Clinical Pharmacy/Pharmacotherapy, Department of Pharmacy, Kyung Hee University College of Pharmacy, Seoul, South Korea; at the time of writing she was a graduate student, Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafeyette, IN. Cole B. Beeler, M.D., is Infectious Diseases Fellow, Indiana University School of Medicine, Indianapolis; at the time of writing he was Chief Internal Medical Resident, Eskenazi Health (formerly Wishard Health Services), Indianapolis. Eva W. Muloma, M.D., is Infectious Diseases Physician, Indiana University Medical Group, and Co-Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) Program, Eskenazi Health. Danielle Osterholzer, M.D., is Infectious Diseases Faculty, Hurley Medical Center, Flint, MI; at the time of writing she was Assistant Clinical Professor of Medicine and Pediatrics, Division of Infectious Diseases, Indiana University School of Medicine, and Section Chief of Infectious Diseases, Eskenazi Health. Kendra M. Damer, Pharm.D., is Associate Professor, Department of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis; at the time of writing she was Assistant Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, and Infectious Diseases Clinical Pharmacy Specialist, Eskenazi Health. Sharon M. Erdman, Pharm.D., is Clinical Professor, Department of Pharmacy Practice, Purdue University College of Pharmacy, and Infectious Diseases Clinical Pharmacist and Co-Director, OPAT Program, Eskenazi Health.
Purpose: The development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) program in a county teaching hospital are described.
Summary: A pharmacist-managed OPAT program was developed and implemented at a county teaching hospital to provide consistent evaluation, approval, and monitoring of patients requiring OPAT for the treatment of infection. The developmental and implementation stages of the OPAT program included (1) a needs assessment, (2) the identification of resources necessary for program operation, (3) delineation of general OPAT program operations and activities of individual OPAT clinicians, (4) the development of patient selection criteria, including a plan of care algorithm, and (5) acquisition of administrative support to approve the program.
Am J Health Syst Pharm
December 2015
Jeffrey J. Cies, Pharm.D., M.P.H., BCPS (AQ-ID), is Pharmacist, St. Christopher's Hospital for Children, Philadelphia, PA, and Pharmacy Clinical Coordinator, Critical Care, and Infectious Diseases Clinical Pharmacist, Alfred I. duPont Hospital for Children, Wilmington, DE. Wayne S. Moore II, Pharm.D., is Pharmacist, Alfred I. duPont Hospital for Children. Arun Chopra, M.D., is Clinician, NYU Langone Medical Center, and Chief, Section of Critical Care Medicine, NYU School of Medicine, New York, NY. Guizhen Lu, B.S., is Research Assistant; and Robert W. Mason, Ph.D., is Head of Clinical Biochemistry, Nemours Biomedical Research, Alfred I. duPont Hospital for Children.
Purpose: The results of a study to determine the stability of solutions of furosemide and chlorothiazide over 96 hours are reported.
Methods: Chlorothiazide and furosemide were diluted in 5% dextrose USP to final concentrations of 10 and 1 mg/mL, respectively, and combined. In addition, sample solutions of chlorothiazide in dextrose, furosemide in dextrose, and dextrose alone were prepared for control purposes.
Am J Health Syst Pharm
December 2015
Professor and Chief of Infectious Diseases, Clement J. Zablocki Veterans Affairs Medical Center and the Medical College of Wisconsin, Milwaukee, WI.
Objective: Prolonged oral antimicrobial suppression has been suggested as an alternative treatment for patients with prosthetic joint infections who are unable or unwilling to undergo surgical intervention; however, little data exists for utilizing this approach in patients with chronic osteomyelitis and no artificial hardware.
Methods: We retrospectively reviewed the medical records of all patients over a 5-year time frame who were treated with chronic oral antibiotic suppression for osteomyelitis and who had no artificial hardware. Clinical outcomes, risk factors for treatment failure, and adverse drug reactions were evaluated.
Ther Adv Urol
August 2015
Infectious Diseases Clinical Pharmacist, Department of Pharmacy - 119, VA Western New York Healthcare System, 3495 Bailey Avenue, Buffalo, NY 14215, USA.
Objectives: The aim of the study was to assess both the safety and the effectiveness of nitrofurantoin in male veterans treated for urinary tract infections (UTIs) with varying degrees of renal impairment in the outpatient setting. Nitrofurantoin is an important oral option for treating UTIs given increasing resistance to commonly used agents. Nitrofurantoin is currently contraindicated in patients with a creatinine clearance (CrCl) of < 60 ml/min, but the reason for this threshold has not been well documented.
View Article and Find Full Text PDFJ Infus Nurs
December 2016
Midwestern University, Chicago College of Pharmacy, Downers Grove, Illinois (Dr McLaughlin, Mr Skoglund); and Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois (Dr McLaughlin). Milena M. McLaughlin, PharmD, MSc, BCPS, AAHIVP, is an assistant professor of pharmacy practice at Midwestern University, Chicago College of Pharmacy in Downers Grove, Illinois, and an infectious diseases clinical pharmacist at Northwestern Memorial Hospital in Chicago. Erik W. Skoglund, BS, is a fourth-professional-year doctor of pharmacy student at Midwestern University, Chicago College of Pharmacy in Downers Grove, Illinois.
Drug shortages present a growing problem in the United States, with the majority of shortages occurring among sterile injectable medications. Although the impact of shortages has been shown to adversely affect patient care in a variety of settings, those who are dependent on outpatient or home infusion therapy are especially vulnerable. Legislative action and the efforts of the U.
View Article and Find Full Text PDFAm J Health Syst Pharm
March 2015
C. Dustin Waters, Pharm. D., BCPS, is Infectious Diseases Clinical Pharmacist, Intermountain Healthcare, McKay-Dee Hospital, Ogden, UT
Purpose: Improved drug-utilization and cost outcomes achieved by a pharmacist-led antimicrobial stewardship program (ASP) are described.
Summary: Pharmacists may be tasked to lead ASP development and implementation with little or no support from an infectious diseases (ID) physician and other hospital personnel whose involvement on ASP teams is recommended (e.g.
Expert Opin Pharmacother
April 2013
Infectious Diseases Clinical Pharmacist, Sharp Grossmont Hospital, Department of Pharmacy, La Mesa, CA, USA.
Introduction: Cytomegalovirus (CMV) infection is a common infectious complication after solid organ transplantation (SOT) and is associated with the increased risk of opportunistic infections and allograft rejection, as well as decreased patient survival. Ganciclovir has been the mainstay antiviral agent for prevention and treatment of CMV; however, its clinical use is hampered by the poor oral bioavailability and the need for intravenous access. Valganciclovir, an oral prodrug of ganciclovir, is up to 10 times more bioavailable than oral ganciclovir and has replaced ganciclovir as a first-line agent in the management of CMV in adult SOT patients.
View Article and Find Full Text PDFAm J Health Syst Pharm
December 2011
Infectious Diseases Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic, OH 44195, USA.